Skip to main content

Trending

  • Ukraine
  • Tucker Carlson
  • Elon Musk

Social Media Menu

  • Facebook
  • Instagram
  • Twitter
  • YouTube

Utility Navigation

  • Take Action
  • Search
  • Donate

Media Matters for America

Main navigation

  • News & Analysis
  • Research & Studies
  • Audio & Video
  • Archives

Media Matters for America

  • Nav
  • Search

Main navigation

  • News & Analysis
  • Research & Studies
  • Audio & Video
  • Archives

Trending

  • Ukraine
  • Tucker Carlson
  • Elon Musk

Utility Navigation

  • Take Action
  • Search
  • Donate

Social Media Menu

  • Facebook
  • Instagram
  • Twitter
  • YouTube
An image of the Cerebral logo and the Instagram logo and dollar bills

Instagram earned millions in advertising dollars from a company under investigation for overprescribing stimulants

Media Matters found that controversial telehealth company Cerebral has spent more than $5 million on Instagram ads since January

Written by Spencer Silva & Camden Carter

Published 05/11/22 10:40 AM EDT

Share

  • Email
  • Twitter
  • Facebook
  • Print

Comment

  • Comments

Cerebral, a telehealth startup that specializes in prescribing medications like Adderall, Ritalin and Xanax over the internet and relies on social media advertising to reach customers, has come under fire for writing a huge number of prescriptions. But Instagram continues to accept the company’s advertising dollars, even as Cerebral has drawn investigations from the Justice Department and the Drug Enforcement Administration. 

A former executive is suing the company, which is worth an estimated $4 billion, on grounds that he was fired for raising concerns internally about Cerebral’s controversial business model — specifically, its habit of seemingly overprescribing stimulants as a ploy to retain customers. The DOJ has reportedly subpoenaed the company for records as part of an investigation into potential violations of the Controlled Substances Act and, per Insider, the DEA has interviewed former Cerebral employees for its own investigation.

Media Matters found that Cerebral spent more than $5 million dollars advertising on Instagram since the beginning of the year. According to Pathmatics, a company that tracks digital marketing data, those ads have earned more than 630 million impressions during the same time period. (The company continues to advertise on TikTok as well.)

And though the company has reportedly paused prescribing controlled substances like Adderall and Ritalin, it’s still running ads on Instagram for ADHD diagnoses and other services.

Three ads for ADHD, weight loss, and depression treatment from Cerebral

Companies like Cerebral are able to legally prescribe potentially addictive medications online because of the coronavirus pandemic. As hospitals and other medical facilities became overwhelmed with COVID-19 patients and millions of Americans began seeing their doctors online, federal authorities relaxed rules that had prohibited controlled substances from being prescribed via telehealth appointments. This resulted in an explosion of telehealth clinics that advertise their services online.

In response to this changing online health care landscape, Instagram's parent company Meta (formerly known as Facebook), updated its advertising policies for prescription drugs last fall. These updates require telehealth providers to undergo a third-party certification process and implement age and location restrictions on telehealth customers. 

After receiving increased public scrutiny around their targeted advertising, Meta announced in January that it planned to remove the option to target advertisements based on what could be considered “sensitive” information,” including “health causes.”

Cerebral isn’t the only company taking advantage of the new telehealth landscape and relaxed federal guidelines around prescribing controlled substances. A startup called Done, for instance, bills itself as a telehealth clinic that treats ADHD. According to Pathmatics, Done has spent more than $800,000 on Instagram ads since the beginning of the year — some of which seemingly violate Meta’s policy against listing prices in ads promoting prescription drugs.

Two ads for ADHD treatment from Done

Both Cerebral and Done have been accused of overprescribing stimulants — in fact, some major pharmacies no longer fulfill prescriptions written by the companies’ clinicians.

Telehealth companies have focused their social media advertising on other treatments as well. Hims & Hers Health, Inc. uses Meta’s platforms to advertise easier and cheaper access to medication for everything from anxiety to erectile dysfunction, with “no office visits or pharmacy trips required.”

Two ads from Hers and Hims for anxiety and ED treatment

Nue Life Health has also published ads through Meta promoting its at-home ketamine treatments for depression.

Two ads from Nue Life for at home ketamine treatment

Telehealth services have proven useful — especially during the pandemic, when many could not see a doctor in person. But when companies prioritize their bottom line to overprescribe medications and utilize targeted advertising with Meta — a company which has also been shown to put its own profits before its users’ safety — it's clear that patient care is no longer the main focus.

Despite Meta’s claims that it has strengthened its advertising policies around prescription medications, the company pockets millions as it enables predatory companies like Cerebral to use its marketing tools to peddle potentially dangerous drugs directly to consumers.

The Latest

  1. The Daily Wire’s Matt Walsh is using a trans man’s shirtless photo without permission to promote an anti-trans documentary

    Article 05/20/22 5:13 PM EDT

  2. Fox guest demands the US deny migrants from “special interest countries” like Cuba

    Video & Audio 05/20/22 4:56 PM EDT

  3. Lara Logan tells QAnon influencer that she is “working with people to establish the Press Club of America”

    Video & Audio 05/20/22 4:02 PM EDT

  4. Charlie Kirk likens Elon Musk to Sean Hannity, says the Tesla CEO is “dispensing red pills on every corner”

    Video & Audio 05/20/22 3:45 PM EDT

  5. Ben Shapiro dismisses the sexual assault report against Elon Musk as “highly non-convincing”

    Video & Audio 05/20/22 3:03 PM EDT

Pagination

  • Current page 1
  • …
  • Next page ››

In This Article

  • Facebook

    Facebook-MMFA-Tag.png
Comments
0 Comments
Share Count
0 Shares

Related

  1. Facebook profited from ads promoting white supremacist “great replacement” theory

    Research/Study 05/20/22 10:00 AM EDT

  2. A network of hate-fueled accounts is thriving on Instagram

    Article 05/18/22 3:49 PM EDT

  3. Media Matters demands oversight and accountability at Meta

    Article 05/17/22 10:31 AM EDT

Media Matters for America

Footer menu

  • About
  • Contact
  • Corrections
  • Submissions
  • Jobs
  • Privacy Policy
  • Terms & Conditions

Social Media Menu

  • Facebook
  • Instagram
  • Twitter
  • YouTube

© 2022 Media Matters for America